Skip to main content
. 2021 Dec 7;21:1307. doi: 10.1186/s12885-021-09021-x

Fig. 5.

Fig. 5

Ivermectin suppressed xenograft growth of ESCC cells in vivo. A, B and C. Tumor growth curves and weight of subcutaneous xenograft tumor model developed from ESCC cells treatment with ivermectin as indicated (n=5); D and E. Representative immunohistochemistry images of Ki67, ROS1, p-p65 and cleaved-caspase 3 in xenograft tumor developed from KYSE-70 and KYSE-30 cells treatment with ivermectin as indicated. Scale bar: 300μm. *P < 0.05, **P < 0.01; ***P < 0.001.